Article
Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes.
EBioMedicine - 1 Nov 2020
Bowker Nicholas, Shah Rupal L, Sharp Stephen J, Luan Jian'an, Stewart Isobel D, Wheeler Eleanor, Ferreira Manuel A R, Baras Aris, Wareham Nicholas J, Langenberg Claudia, Lotta Luca A
Abstract excerpt
BACKGROUND: Evidence from animal models and observational epidemiology points to a role for chronic inflammation, in which interleukin 6 (IL-6) is a key player, in the pathophysiology of type 2 diabetes (T2D). However, it is unknown whether IL-6 mediated inflammation is implicated in the pathophysiology of T2D. METHODS: We performed a meta-analysis of 15 prospective studies to investigate associations between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
